𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non-A non-B hepatitis — Quandaries in serological testing and treatment

✍ Scribed by M.E. Ellis


Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
450 KB
Volume
21
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Non-A, non-B hepatitis in children: A cl
✍ Shun-Chien Hsu; Mei-Hwei Chang; Ding-Shinn Chen; Hey-Chi Hsu; Chin-Yun Lee 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

## Abstract Twenty‐seven children with non‐A, non‐B hepatitis were studied with regard to their clinical, serologic, and histologic features. In contrast to adult patients, non‐A, non‐B hepatitis developed in most pediatric patients (19 out of 27) in the absence of identifiable parenteral exposure,

Serological studies of an enterically tr
✍ Isa K. Mushahwar; George J. Dawson; Khalif M. Bile; Lars O. Magnius 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

## Abstract An outbreak of an acute sporadic viral hepatitis occurring at three villages in the lower Shebli region of southern Somalia was studied. Sera were examined for antibodies to hepatitis E virus (HEV) antigen by a recently developed enzymelinked immunosorbent assay. The prevalence of anti‐

Non-A, Non-B Hepatitis
✍ Jack R. Wands 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views
Non-A, non-B hepatitis in Omdurman, Suda
✍ M. A. Al-Arabi; M. Mahgoub; A. A. Ai-Hag; K. C. Hyams; N. El-Ghorab 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

One-hundred nineteen patients (cases) at least 13 years of age with acute hepatitis were studied to determine the viral etiology of acute hepatitis in Omdurman, Sudan. Ninety-eight control subjects (controls) were also evaluated to determine the risk factors associated with the development of clinic

Treatment of chronic non-A, non-B hepati
✍ S. Chris Pappas; Dr. Jay H. Hoofnagle; Neal Young; Stephen E. Straus; E. Anthony 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Five patients with chronic non-A, non-B hepatitis were entered into a pilot therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl) guanine]. Each patient received acyclovir by slow intravenous infusion in a dosage of 5 mg/kg every 8 hr for 10 days. During therapy, serum aminot